Featured
September 16, 2026
To celebrate Open Science Week, ASAP highlights how transparent collaboration and open data sharing are driving research forward across our network to accelerate Parkinson's discoveries.
Read More
To celebrate Open Science Week, ASAP highlights how transparent collaboration and open data sharing are driving research forward across our network to accelerate Parkinson's discoveries.
Read More
The Jewish Chronicle highlights a Lancet study by Global Parkinson's Genetics Program (GP2), a resource program of ASAP, which represents the largest-ever global assessment of Parkinson’s genetics across 11 ancestries and reveals that a specific variant is present in over 25% of Ashkenazi Jews with the condition.
View Story
In this blog, Hetal Shah, PhD, senior program officer, and Dana Lewis, PhD, program officer at ASAP and the Coalition for Aligning Science, discuss highlights from the 2026 CRN Annual Investigators Meeting, emphasizing how new research themes and cross-disciplinary collaboration are accelerating progress in Parkinson’s disease research.
Read More
The National highlights a Lancet study by the Global Parkinson’s Genetics Program (GP2), a resource program of ASAP, revealing significant blind spots in addressing the needs of Middle Eastern populations, despite high regional rates of key genetic variants linked to Parkinson’s disease.
View Story
In this blog, ASAP shares an overview of the Collaborative Research Network (CRN) 2025–2026 Impact Report, highlighting key discoveries, cross-cutting scientific themes, field-enabling resources, and infrastructure efforts accelerating breakthroughs in Parkinson's disease research.
Read More
SPARC dives into how Aligning Science Across Parkinson's (ASAP) and The Michael J. Fox Foundation (MJFF) are advancing Parkinson's research through open-access and open-science policies that mandate the early, public sharing of publications, data, protocols, and lab resources.
View Story
The Jewish News reports on a study by the Global Parkinson’s Genetics Program (GP2), a resource program of ASAP, showing the role genetics plays in Parkinson’s in Jewish patients and how they are well placed to benefit from emerging precision treatments.
View Story
In a commentary published in Bio-IT World, ASAP Managing Director Sonya Dumanis shares how Parkinson's disease diagnosis and treatment is shifting away from broad symptom management towards a precision medicine approach grounded in molecular profiling, novel biomarkers, and global data-sharing.
View Story
In this Q2 2026 edition of the ASAP Research Round-Up, we highlight how our programs produced resources for the scientific community, supported venues that facilitate collaboration, and provided new opportunities for researchers to accelerate discoveries in Parkinson’s research.
Read More
